This compounded medication is not affiliated with or endorsed by Eli Lilly and is not intended as a substitute for FDA-approved products
Insert the syringe on the peptide vial without shaking the powder
Many patients notice improvements in pain, inflammation, or recovery within 1-2 weeks, though timing varies based on the condition being addressed, severity of injury, route of administration, and individual healing capacity
2022;46:e14264
This test does not predict exact medication response or guarantee outcomesinstead, it provides one biological data point among many that inform personalized treatment planning
Eli Lilly, the compound developer, is running the Phase 3 TRIUMPH clinical trial program, and FDA approval is not expected before 2027 at the earliest